Company / Profit Margin
TREACE MEDICAL CONCEPTS, INC. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-26.5%
FY2025
5-year range
-30.2% / -6.4%
FY2021-FY2025
Trend
+12.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin returned to growth in FY2025 after 2 years of decline, reaching -26.5%.
Based on SEC 10-K filings.
-26.5% in FY2025 with a 3-year CAGR of -20.1%.
Declined from -21.8% to -26.5% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -20.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 12.3% year-over-year.
- Peak profit margin was recorded in FY2022.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -26.5% | +12.3% |
| FY2024 | -30.2% | -38.7% |
| FY2023 | -21.8% | -240.7% |
| FY2022 | -6.4% | +40.9% |
| FY2021 | -10.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026